<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03290014</url>
  </required_header>
  <id_info>
    <org_study_id>PR(AG)365/2015</org_study_id>
    <nct_id>NCT03290014</nct_id>
  </id_info>
  <brief_title>Sleep Quality in (COPD) Patients (COPD: Chronic Obstructive Pulmonary Disease)</brief_title>
  <acronym>COPD</acronym>
  <official_title>Sleep Quality in COPD Patients. A Clinical and Polysomnographic Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitari Vall d'Hebron Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>AstraZeneca</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Universitari Vall d'Hebron Research Institute</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with COPD, in addition to daytime symptoms, may suffer from nocturnal disturbances.
      The frequency of nocturnal problems has been reported to be higher in COPD than in the
      general population and it currently affects up to 50% of patients.

      The CASIS questionnaire includes 7 questions and it has been recently validated as an
      objective tool to evaluate nocturnal symptoms in patients with asthma and COPD. The present
      study aims to study the validity of the CASIS questionnaire as a predictor of sleep quality
      measured by objective polysomnographic parameters.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2017</start_date>
  <completion_date type="Anticipated">September 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Sleep efficiency</measure>
    <time_frame>One night at the sleep unit</time_frame>
    <description>Sleep time/Time in bed</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total sleep time</measure>
    <time_frame>One night at the sleep unit</time_frame>
    <description>Total sleep time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arousal index</measure>
    <time_frame>One night at the sleep unit</time_frame>
    <description>number of arousals/hour of sleep</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>sleep architecture</measure>
    <time_frame>One night at the sleep unit</time_frame>
    <description>percentage of the different sleep phases</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Osler test error index</measure>
    <time_frame>Next morning after polysomnography (8a.m.--4 p.m.)</time_frame>
    <description>number of errors</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Actigraphy</measure>
    <time_frame>One week previous to polysomnography</time_frame>
    <description>Monitoring of rest/activity cycles</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">58</enrollment>
  <condition>COPD</condition>
  <arm_group>
    <arm_group_label>Good sleepers</arm_group_label>
    <description>COPD patients with good sleep quality according to CASIS score will be studied with polysomnography, actigraphy and OSLER test</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bad sleepers</arm_group_label>
    <description>COPD patients with poor sleep quality according to CASIS score will be studied with polysomnography, actigraphy and OSLER test</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>polysomnography</intervention_name>
    <description>Monitoring of brain activity and respiratory variables during sleep</description>
    <arm_group_label>Good sleepers</arm_group_label>
    <arm_group_label>Bad sleepers</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Actigraphy</intervention_name>
    <description>monitoring daily physical activity for 7 days</description>
    <arm_group_label>Good sleepers</arm_group_label>
    <arm_group_label>Bad sleepers</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Osler test</intervention_name>
    <description>Evaluation of subjects´ ability to remain awake</description>
    <arm_group_label>Good sleepers</arm_group_label>
    <arm_group_label>Bad sleepers</arm_group_label>
    <other_name>Oxford sleep resistance test</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Consecutive patients aged 40-80 years, smokers or exsmokers of at least 10 pack-years,
        diagnosed with moderate-to-severe COPD (post bronchodilator FEV1% &lt; 70% and FEV1 ≥ 30 but &lt;
        80% of predicted in a spirometry performed within 6 months prior to inclusion into the
        study)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:

        Patients with written inform consent to participate in the study and all the following
        criteria will be selected:

          -  Age 40-80 years

          -  Smokers or exsmokers of at least 10 pack-years

          -  Moderate-to-severe COPD

        Exclusion criteria:

          -  Non-stable COPD. Stability is defined as being exacerbation free and without treatment
             changes for at least 4 weeks prior to baseline evaluation. The presence of a COPD
             exacerbation previous to the sleep studies (polysomnography, actigraphy, OSLER test)
             will lead to an early discontinuation of the patient´s participation in the study.

          -  Heart failure, asthma, cancer or other major medical illness with known effects on
             sleep quality.

          -  Unable to understanding the questionnaires administered in the study.

          -  Known Obstructive Sleep Apnea, other sleep disorder (narcolepsy, periodic limb
             movements) or shift work.

          -  Chronic respiratory failure (PaO2 &lt;60 mmHg).

          -  Treatment with sedatives or antidepressants.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marc Miravitlles, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Vall d´Hebron Institut de Recerca</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gabriel Sampol, PhD</last_name>
    <phone>+34932746083</phone>
    <email>gsampol@vhebron.net</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jaume Ferrer, PhD</last_name>
    <phone>+34932746083</phone>
    <email>jjferrer@vhebron.net</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Universitari Vall d´Hebron</name>
      <address>
        <city>Barcelona</city>
        <zip>08034</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gabriel Sampol, PhD</last_name>
      <phone>+34932746083</phone>
      <email>gsampol@vhebron.net</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Pokrzywinski RF, Meads DM, McKenna SP, Glendenning GA, Revicki DA. Development and psychometric assessment of the COPD and Asthma Sleep Impact Scale (CASIS). Health Qual Life Outcomes. 2009 Dec 7;7:98. doi: 10.1186/1477-7525-7-98.</citation>
    <PMID>19968881</PMID>
  </reference>
  <reference>
    <citation>Miravitlles M, Iriberri M, Barrueco M, Lleonart M, Villarrubia E, Galera J. Usefulness of the LCOPD, CAFS and CASIS scales in understanding the impact of COPD on patients. Respiration. 2013;86(3):190-200. doi: 10.1159/000341175. Epub 2012 Oct 2.</citation>
    <PMID>23037958</PMID>
  </reference>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 8, 2017</study_first_submitted>
  <study_first_submitted_qc>September 17, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 21, 2017</study_first_posted>
  <last_update_submitted>September 17, 2017</last_update_submitted>
  <last_update_submitted_qc>September 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

